Cardiff surgical company showcases UK healthcare innovation in Texas

A spin-out medical device company from a leading surgical training institute at Cardiff University is one of 12 UK companies representing the country’s health and life science industry in Texas next week (15th to 21st October 2016).Alesi Surgical, developer of the revolutionary Ultravision system, which manages surgical smoke during laparoscopic keyhole surgery, will form part […]

New global market for Alesi Surgical

Alesi Surgical Limited, the advanced minimally invasive surgery medical device manufacturer, has announced its entry into the lucrative trocar market estimated to be worth $800 million per year, globally.

Alesi Surgical announces key appointment to strengthen sales and marketing for its lead product, Ultravision™

Alesi Surgical the medical device company developing novel technologies to enhance outcomes in minimally invasive surgery, announced the appointment of Marcus Dyer as International Sales and Marketing Manager.

Alesi Surgical has announced that it will be sponsoring the 23rd European Association for Endoscopic Surgery (EAES) Congress, Bucharest, 3–6 June 2015.

The company will be demonstrating its lead product, Ultravision™ which eliminates surgical smoke during laparoscopic (keyhole) surgery and provides a continuously clear visual field for the operating surgeon. Ultravision uses electrostatic precipitation, a proven method of clearing vapour and particulate matter, which otherwise would be released into the operating room. Dr Dominic Griffiths, Managing Director […]

Alesi Surgical secures £2.1m funding to drive commercialisation of Ultravision Funding to drive adoption via new distributor network

Alesi Surgical (formerly Asalus Medical Instruments Limited) announced today that it has secured additional funding of £2.1 million to drive the further commercialisation of its lead product, UltravisionTM, which was developed from concept to CE-marked device with backing from IP Group and Finance Wales. The funding comes at an important inflection point for the Company. […]